Aytu Biopharma (AYTU) Retained Earnings: 2009-2025
Historic Retained Earnings for Aytu Biopharma (AYTU) over the last 16 years, with Sep 2025 value amounting to -$331.6 million.
- Aytu Biopharma's Retained Earnings fell 4.10% to -$331.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$331.6 million, marking a year-over-year decrease of 4.10%. This contributed to the annual value of -$333.5 million for FY2025, which is 4.24% down from last year.
- Aytu Biopharma's Retained Earnings amounted to -$331.6 million in Q3 2025, which was up 0.59% from -$333.5 million recorded in Q2 2025.
- Over the past 5 years, Aytu Biopharma's Retained Earnings peaked at -$159.3 million during Q1 2021, and registered a low of -$333.5 million during Q2 2025.
- Over the past 3 years, Aytu Biopharma's median Retained Earnings value was -$315.4 million (recorded in 2024), while the average stood at -$316.5 million.
- As far as peak fluctuations go, Aytu Biopharma's Retained Earnings plummeted by 69.99% in 2022, and later rose by 0.53% in 2025.
- Quarterly analysis of 5 years shows Aytu Biopharma's Retained Earnings stood at -$217.7 million in 2021, then plummeted by 35.28% to -$294.5 million in 2022, then fell by 6.11% to -$312.5 million in 2023, then fell by 1.67% to -$317.7 million in 2024, then fell by 4.10% to -$331.6 million in 2025.
- Its Retained Earnings was -$331.6 million in Q3 2025, compared to -$333.5 million in Q2 2025 and -$313.7 million in Q1 2025.